{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:44:24Z","timestamp":1773287064044,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T00:00:00Z","timestamp":1466726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T00:00:00Z","timestamp":1466726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["00220848"],"award-info":[{"award-number":["00220848"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K06880"],"award-info":[{"award-number":["15K06880"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13104-016-2128-x","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T13:01:40Z","timestamp":1466773300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment of anti-mesothelioma monoclonal antibodies"],"prefix":"10.1186","volume":"9","author":[{"given":"Natsuko","family":"Mizutani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kajino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Wakiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Ohtsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikao","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okio","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,24]]},"reference":[{"issue":"Suppl 1","key":"2128_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.lungcan.2005.03.002","volume":"49","author":"L Kazan-Allen","year":"2005","unstructured":"Kazan-Allen L. Asbestos and mesothelioma: worldwide trends. Lung Cancer. 2005;49(Suppl 1):S3\u20138.","journal-title":"Lung Cancer"},{"key":"2128_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"5","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;5:397\u2013408.","journal-title":"Lancet"},{"key":"2128_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI, Yang H. Malignant mesothelioma: facts, myths and hypotheses. J Cell Physiol. 2012;227:44\u201358.","journal-title":"J Cell Physiol"},{"key":"2128_CR4","unstructured":"US Department of the Interior, US Geological Survey. Mineral commodity summaries 2015. 2015. p. 22\u201323."},{"key":"2128_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/(SICI)1097-0339(199910)21:4<253::AID-DC5>3.0.CO;2-N","volume":"21","author":"G Nguyen","year":"1999","unstructured":"Nguyen G, Akin MM, Villanueva RR, Slatnik J. Cytopathology of malignant mesothelioma of the pleura in fine-needle aspiration biopsy. Diagn Cytopathol. 1999;21:253\u20139.","journal-title":"Diagn Cytopathol"},{"key":"2128_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1365-2303.2000.00247.x","volume":"11","author":"D Whitaker","year":"2000","unstructured":"Whitaker D. The cytology of malignant mesothelioma. Cytopathology. 2000;11:139\u201351.","journal-title":"Cytopathology"},{"key":"2128_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.legalmed.2007.06.001","volume":"10","author":"A Fassina","year":"2008","unstructured":"Fassina A, Fedeli U, Corradin M, Da FM, Fabbris L. Accuracy and reproducibility of pleural effusion cytology. Leg Med. 2008;10:20\u20135.","journal-title":"Leg Med"},{"key":"2128_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/dc.20747","volume":"36","author":"RT Pu","year":"2008","unstructured":"Pu RT, Pang Y, Michael CW. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (CK903 and CK5\/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol. 2008;36:20\u20135.","journal-title":"Diagn Cytopathol"},{"key":"2128_CR9","first-page":"128","volume-title":"Pathology and genetics. Tumours of the lung, pleura, thymus and heart","author":"A Chung","year":"2004","unstructured":"Chung A, Inai K, Samet J. Tumor of the pleura. In: Travis WD, Muller BE, Hermelink HK, Harris CG, editors. Pathology and genetics. Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 128\u201342."},{"key":"2128_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591\u2013603.","journal-title":"N Engl J Med"},{"key":"2128_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12199-007-0017-6","volume":"13","author":"K Inai","year":"2008","unstructured":"Inai K. Pathology of mesothelioma. Environ Health Prev Med. 2008;13:60\u20134.","journal-title":"Environ Health Prev Med"},{"key":"2128_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1053\/hupa.2002.128248","volume":"33","author":"NG Ord\u00f3\u00f1ez","year":"2002","unstructured":"Ord\u00f3\u00f1ez NG. Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers. Hum Pathol. 2002;33:953\u201367.","journal-title":"Hum Pathol"},{"key":"2128_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","volume":"16","author":"NG Ord\u00f3\u00f1ez","year":"2003","unstructured":"Ord\u00f3\u00f1ez NG. Value of mesothelin immunostaining in the diagnosis of mesothelioma. Mod Pathol. 2003;16:192\u20137.","journal-title":"Mod Pathol"},{"key":"2128_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5858\/arpa.2010-0604-RA","volume":"136","author":"P Betta","year":"2012","unstructured":"Betta P, Magnani C, Bensi T, Trincheri FN, Oreccha S. Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma. Arch Pathol Lab Med. 2012;136:253\u201361.","journal-title":"Arch Pathol Lab Med"},{"key":"2128_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.lungcan.2009.01.011","volume":"66","author":"Y Takeshima","year":"2009","unstructured":"Takeshima Y, Inai K, Amatha V, Gemba K, Aoe K, Fujimoto N, Kato K, Kishimoto T. Accurancy of pathological diagnosis of mesothelioma cases in Japan: clinicopathological analysis of 382 cases. Lung Cancer. 2009;66:191\u20137.","journal-title":"Lung Cancer"},{"key":"2128_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cllc.2012.03.011","volume":"14","author":"CS Kao","year":"2013","unstructured":"Kao CS, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, Zandwijk NV, Clarke S. Validation of prognostic factors in malignant pleural mesothelioma. Clin Lung Cancer. 2013;14:70\u20137.","journal-title":"Clin Lung Cancer"},{"key":"2128_CR17","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","volume":"13","author":"T Inamoto","year":"2007","unstructured":"Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, Inamoto S, Katsuoka Y, Hosono O, Tanaka H, Dang NH, Morimoto C. Humanized Anto-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res. 2007;13:4191\u2013200.","journal-title":"Clin Cancer Res"},{"key":"2128_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2867-9-17","volume":"9","author":"K Yamada","year":"2009","unstructured":"Yamada K, Hayashi M, Du W, Ohnuma K, Sakamoto M, Morimoto C. Yamada T. cc. Cancer Cell International. 2009;9:17.","journal-title":"Cancer Cell International"},{"key":"2128_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495\u20137.","journal-title":"Nature"},{"key":"2128_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/BF01542654","volume":"5","author":"H Koprowski","year":"1979","unstructured":"Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979;5:957\u201372.","journal-title":"Somatic Cell Genet"},{"key":"2128_CR21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"68","author":"CR Bast","year":"1981","unstructured":"Bast CR, Feeney M, Lazarus H, Nadler LM, Colvin BR, Knapp CR. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331\u20137.","journal-title":"J Clin Invest"},{"issue":"6","key":"2128_CR22","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-L\u00f3pez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma. Blood. 1997;90(6):2188\u201395.","journal-title":"Blood"},{"key":"2128_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1440-1827.2009.02344.x","volume":"59","author":"K Ishikawa","year":"2009","unstructured":"Ishikawa K, Segawa T, Hagiwara Y, Maeda M, Abe M, Hino O. Establishment of novel monoclonal antibody to human ERC\/mesothelin useful for study and diagnosis of ERC\/mesothelin-expressing cancers. Pathol Int. 2009;59:161\u20136.","journal-title":"Pathol Int"},{"key":"2128_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF01518520","volume":"37","author":"GD Lewis","year":"1993","unstructured":"Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C, Shepard HM. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies. Cancer Immunol Immunother. 1993;37:255\u201363.","journal-title":"Cancer Immunol Immunother"},{"key":"2128_CR25","first-page":"401","volume":"26","author":"WS Kwee","year":"1982","unstructured":"Kwee WS, Veldhuizen RW, Alons CA, Morawetz F, Boon ME. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid. Acta Cytol. 1982;26:401\u20136.","journal-title":"Acta Cytol"},{"key":"2128_CR26","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-11-1990","volume":"18","author":"K Aoe","year":"2012","unstructured":"Aoe K, Amatya VJ, Fujimoto N, Ohnuma K, Hosono O, Hiraki A, Fujii M, Yamada T, Dang NH, Takeshima Y, Inai K, Kishimoto T, Morimoto C. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma. Clin Cancer Res. 2012;18:1447\u201356.","journal-title":"Clin Cancer Res"},{"key":"2128_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-30","author":"R Hatano","year":"2014","unstructured":"Hatano R, Yamada T, Matsuoka S, Iwata S, Yamazaki H, Komiya E, Okamoto T, Dang NM, Ohnuma K, Morimoto C. Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue. Diagn Pathol. 2014. doi:\n                    10.1186\/1746-1596-9-30\n                    \n                  .","journal-title":"Diagn Pathol"},{"key":"2128_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"BW Robinson","year":"2003","unstructured":"Robinson BW, Creaney J, Lake R, Nowark A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Helstrom I. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003;362:1612\u20136.","journal-title":"Lancet"},{"key":"2128_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","volume":"15","author":"I Hellstrom","year":"2006","unstructured":"Hellstrom I, Raycraft J, Kanan S, Sardesai NY, Verch T, Yang Y, Hellstrom KH. Mesothelin variant 1 is released from tumor cells as a diagnostic marker. Cancer Epidemiol Biomark Prev. 2006;15:1014\u201320.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2128_CR30","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","volume":"6","author":"N Scholler","year":"1999","unstructured":"Scholler N, Fu N, Yang Y, Ye Z, Goodman GE, Hellstrom KE, Hellstrom I. Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci USA. 1999;6:11531\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2128_CR31","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2001.19.8.2165","volume":"19","author":"SM O\u2019Brien","year":"2001","unstructured":"O\u2019Brien SM, Kantarjian H, Thomas DA, Giles FJ, Freireich EJ, Cortes J, Lemer S, Keating MJ. Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol. 2001;19:2165\u201370.","journal-title":"J Clin Oncol"},{"key":"2128_CR32","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1084\/jem.181.6.2007","volume":"181","author":"S Matsuoka","year":"1995","unstructured":"Matsuoka S, Asano Y, Sano K, Kishimto H, Yamashita I, Yorifuji H, Utsuyama M, Hirokawa K, Tada T. A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of lymphocytes. J Exp Med. 1995;181:2007\u201315.","journal-title":"J Exp Med"},{"key":"2128_CR33","first-page":"528","volume":"3","author":"FM Yuniel","year":"2008","unstructured":"Yuniel FM, Alejandro LR. Lonely killers. mAbs. 2008;3:528\u201334.","journal-title":"mAbs"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-016-2128-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2128-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:44:54Z","timestamp":1589539494000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-016-2128-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2128"],"URL":"https:\/\/doi.org\/10.1186\/s13104-016-2128-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,24]]},"assertion":[{"value":"20 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"324"}}